Clinical Trials Directory

Trials / Completed

CompletedNCT00608920

Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping

SPECT Lymph Node Mapping to Define Nodal Clinical Target Volume in Patients With Prostate Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if the planning of radiation treatment of prostate cancer patient can be made more precise by comparing currently planning techniques to an imaging technique called SPECT.

Detailed description

Single photon emission computed tomography (SPECT) uses radioactive tracers and a scanner to record data that a computer constructs into two- or three-dimensional images. A small amount of a radioactive drug is injected into the body and a scanner is used to make detailed images of areas inside the body where the radioactive material is taken up by the cells. Using a gamma camera (a special kind of scanner), we can create a better picture of the lymph node region. We will compare these pictures to images from your CT scan, to help plan your therapy. The research in this study involves seeing if it is feasible to use SPECT scanning procedures for the purpose of planning your radiation treatment. We hope that doing so will allow us to more accurately and precisely plan radiation treatment to potential sites of cancer, and avoid delivering too much radiation to normal

Conditions

Interventions

TypeNameDescription
OTHERSingle Photon Emission Computed Tomography (SPECT)

Timeline

Start date
2007-03-01
Primary completion
2009-04-01
Completion
2009-04-01
First posted
2008-02-06
Last updated
2013-05-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00608920. Inclusion in this directory is not an endorsement.